These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24622319)

  • 1. Diabetes treatments and cancer risk: the importance of considering aspects of drug exposure.
    Walker JJ; Johnson JA; Wild SH
    Lancet Diabetes Endocrinol; 2013 Oct; 1(2):132-9. PubMed ID: 24622319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and cancer.
    Chowdhury TA
    QJM; 2010 Dec; 103(12):905-15. PubMed ID: 20739356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of drugs related to the treatment of diabetes mellitus and other cardiovascular risk factors in the Spanish population. The Di@bet.es study.
    Rojo-Martínez G; Valdés S; Colomo N; Lucena MI; Gaztambide S; Gomis R; Casamitjana R; Carmena R; Catalá M; Martínez-Larrad MT; Serrano-Ríos M; Castaño L; Vendrell J; Girbés J; Franch J; Vázquez JA; Mora-Peces I; Urrutia I; Pascual-Manich G; Ortega E; Menéndez E; Delgado E; Bordiú E; Castell C; López-Alba A; Goday A; Calle A; Bosch-Comas A; Soriguer F
    Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):854-63. PubMed ID: 24773992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global implications of diabetes and cancer.
    Shi Y; Hu FB
    Lancet; 2014 Jun; 383(9933):1947-8. PubMed ID: 24910221
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes and cancer: a consensus report.
    Giovannucci E; Harlan DM; Archer MC; Bergenstal RM; Gapstur SM; Habel LA; Pollak M; Regensteiner JG; Yee D
    Diabetes Care; 2010 Jul; 33(7):1674-85. PubMed ID: 20587728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes and cancer: an injurious association].
    Gariani K; Tran C; Philippe J
    Rev Med Suisse; 2010 Jun; 6(252):1193-4, 1196-8. PubMed ID: 20614754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes and the risk for colorectal cancer.
    Erbach M; Mehnert H; Schnell O
    J Diabetes Complications; 2012; 26(1):50-5. PubMed ID: 22321219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes mellitus in sub-Saharan Africa: epidemiological aspects and management issues].
    Gning SB; Thiam M; Fall F; Ba-Fall K; Mbaye PS; Fourcade L
    Med Trop (Mars); 2007 Dec; 67(6):607-11. PubMed ID: 18300524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population-based cohort study.
    Lin CC; Lai MS; Shau WY
    Diabet Med; 2015 Mar; 32(3):324-31. PubMed ID: 25252097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
    Gallagher EJ; LeRoith D
    Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):485-94. PubMed ID: 23974779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illuminating the diabetes-cancer link.
    Brower V
    J Natl Cancer Inst; 2012 Jul; 104(14):1048-50. PubMed ID: 22781433
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-cancer activity of metformin: new perspectives for an old drug].
    Beck E; Scheen AJ
    Rev Med Suisse; 2010 Sep; 6(260):1601-7. PubMed ID: 20853715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From obesity to diabetes and cancer: epidemiological links and role of therapies.
    García-Jiménez C; Gutiérrez-Salmerón M; Chocarro-Calvo A; García-Martinez JM; Castaño A; De la Vieja A
    Br J Cancer; 2016 Mar; 114(7):716-22. PubMed ID: 26908326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risks from diabetes therapies: evaluating the evidence.
    Li C; Kong D
    Pharmacol Ther; 2014 Oct; 144(1):71-81. PubMed ID: 24844968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review.
    Patorno E; Garry EM; Patrick AR; Schneeweiss S; Gillet VG; Zorina O; Bartels DB; Seeger JD
    Drug Saf; 2015 Mar; 38(3):295-310. PubMed ID: 25761856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure and diabetes mellitus: epidemiology and management of an alarming association.
    Cohen-Solal A; Beauvais F; Logeart D
    J Card Fail; 2008 Sep; 14(7):615-25. PubMed ID: 18722328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes, treatments for diabetes and their effect on cancer incidence and mortality: attempts to disentangle the web of associations.
    Wild SH
    Diabetologia; 2011 Jul; 54(7):1589-92. PubMed ID: 21541783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological bases and molecular mechanisms linking obesity, diabetes, and cancer.
    Gutiérrez-Salmerón M; Chocarro-Calvo A; García-Martínez JM; de la Vieja A; García-Jiménez C
    Endocrinol Diabetes Nutr; 2017 Feb; 64(2):109-117. PubMed ID: 28440775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of treatment for diabetes during 1997-2007, and trends in cardiovascular risk factors between 2001 and 2007 according to diabetic treatment, in the IPC (Investigations Préventives et Cliniques; Preventive and Clinical Investigations) cohort.
    Thomas F; Eschwege E; Bean K; Pannier B; Danchin N
    Diabetes Metab; 2013 Sep; 39(4):343-8. PubMed ID: 23642643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
    Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
    Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.